Wyeth reveals probe
Tuesday, Feb. 11, 2003 | 9:49 a.m.
MADISON, N.J. -- Wyeth today said it expects a subpoena from the U.S. Justice Department for an inquiry into allegations of "collusive" sales practices with another drugmaker.
The company, whose hormone replacement treatments were tied to cancer and heart risks last year, made the disclosure in a regulatory filing and said the allegations are related to commissions for a "small segment of the over-the-counter drug business." The filing didn't name another pharmaceutical company.
archive
Most Popular
- Viewed
- Discussed
- E-mailed
- Details on real estate agents’ roles in HOA fraud revealed
- Las Vegas woman hits $2.2 million jackpot at Orleans
- High school softball coach accused of sexual relations with student-athlete
- Ga. woman battling flesh-eating bacteria speaks
- Beneath his stark ambition and polished public persona, Brian Sandoval is a nerd






Facebook Connect